CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

Recruiting now

Conditions studied: Alopecia Areata

In brief

Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers. Visit schedules for patients will be determined by the provider in accordance with routine clinical care, and any prescriptions provided to patients will adhere to product availability and local prescribing guidelines/regulations in the country where the participating registry site is located.

Key facts

Study ID

NCT06562270

Run by

CorEvitas

People needed

1500

Starts

2024-03-07

Expected to finish

2099-12-31

Last updated by the study team

2026-02-09

Who can join

Age: 12 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• To be eligible to participate in this registry, an individual must meet all the following criteria:
• Has ever been diagnosed with severe AA by a dermatologist or a qualified dermatology provider.
• Is 12-17 years of age at the time of enrollment.
• Is willing to provide consent/assent for participation in the registry.
• Has been prescribed a new commercially available advanced therapy and/or conventional systemic therapy for the treatment of severe AA in adolescents in the context of routine clinical care that is consistent with local prescribing guidelines and/or regulations for the country where the site is located.
• A new therapy is a medication that the subject has never taken before.
• At the time of registry enrollment OR
• Within 6 months prior to registry enrollment In the opinion of the treating provider, is deemed a candidate for treatment with a commercially available advanced therapy and/or conventional systemic therapy for the treatment of severe AA in adolescents but has not received nor is planning to initiate treatment at the time of registry enrollment.

You may not qualify if…

• An individual who meets any of the following criteria will be excluded from participation in the registry:
• Is participating or planning to participate in a blinded clinical trial for any investigational medication.
• Is unwilling or unable to provide standing height measurements.

Where it is running

• CorEvitas, LLC — Waltham, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.